1. Jaime Mora, William L. Gerald, Jing Qin and Nai-Kong V. Cheung. “Molecular Genetics of Neuroblastoma and the Implications for Clinical Management: A Review of the MSKCC Experience”. The Oncologist 6: 263-268, 2001. 2. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV and Roald B. “Terminology and morphologic criteria of neuroblastic tumors: recommendations by the Internacional Neuroblastoma Pathology Committee”. Cancer 86(2): 349-363, 1999. 3. Francisco López-Lara Martín, Carmen González San Segundo, Juan Antonio Santos Miranda y Álvaro Sanz Rubiales. “Manual de Oncología Clínica”, 1999. 4. Jay L. Grosfeld. “Risk-based Management of Solid Tumors in Children”. The American Journal of Surgery 180: 322-327, 2000. 5. Frank Westermann and Manfred Schwab. “Genetic parameters of neuroblastomas”. Cancer Letters 184: 127-147, 2002. 6. N Bown. “Neuroblastoma tumour genetics: clinical and biological aspects”. Journal of Clinical Pathology 54: 897-910, 2001. 7. Thorner PS and Squire JA. “Molecular genetics in the diagnosis and prognosis of solid pediatric tumors”. Pediatr Dev Pathol 1: 337-365, 1998. 8. Mertens, F, et al.,Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Research 57: 2765-2780, 1997. 9. Se K Kim, et al, Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer. Oncogene 17: 1749-1753, 1998. 10. Hironori F, et, al, Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Am J Pathol 155: 387-394, 1999. 11. Albarosa R, et al, Deletion Mapping of gliomas suggests the presence of two small regions for candidate tumor supresor genes in a 17-cM intervalo n chromosome 10. Am J Humm Genet 58: 1260-1267, 1996 12. Sanson M, et al, Análisis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas. J Neurosurg 97: 1397-1401, 2002. 13. Terada K, et al, Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas. Journal of Neuro-Oncology 58: 107-114, 2002. 14. Peiffer-Schneider S, et al, Mapping an endometrial cancer tumor supresor gene at 10q25 and development of a bacterial clone contig for the consensos deletion interval. Genomics 52: 9-16, 1998. 15. Mark A. Rubin, et al, 10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3, N+) versus lymph node-negative (pT2-3, NO) prostate cancer. Hum Pathol 31: 504-508, 2000.
|